Products & Brands Using Bacillus Coagulans

Weizmannia coagulans BC99

Identifiers

FormulaC3H6O3·CAS50-21-5·EC200-018-0·HS2918.11

Hazards

CorrosiveIrritant

How broadly is Bacillus coagulans used across tracked brands and products?

Brands

1

Across 2 product types

Products

23

Product Types

2

Distinct formulation categories

Functions

0

Known functional-use labels

What does product breadth indicate about the commercial maturity of bacillus coagulans?

Product breadth indicates low commercial maturity. Only two commercial products exist, both from one brand, both launched in 2019, and both confined to facial care. This suggests minimal market adoption and limited category diversification. In contrast, the patent landscape shows substantial developmental activity across at least 70 patents spanning food, beverage, pharmaceutical, cosmetic, and agricultural applications, with recent publications through 2026. The gap between active patent development and sparse commercial product presence suggests the ingredient is in an early commercialization phase, with technology transfer and product launches still emerging.

How is bacillus coagulans positioned across the market?

Commercially, bacillus coagulans is positioned as a probiotic skin-care ingredient within a single brand's facial care line, with no evidence of broader market positioning. Patent evidence positions it far more expansively as a multifunctional probiotic with strain-specific benefits: blood glucose reduction, uric acid lowering, anti-aging and stress defense, intestinal flora regulation, physical performance enhancement, and metabolic health applications. The commercial positioning appears nascent and undifferentiated compared to the patent landscape, which emphasizes specific strain deposits and targeted health outcomes.

Top companies using Bacillus coagulans in their products

Ranked by number of tracked products that list bacillus coagulans, out of 23 total.

Which product categories, formats, and functions use bacillus coagulans?

Commercial product evidence shows bacillus coagulans in only two facial care formats—a face wash and a face cream/moisturizer—both from a single brand and published in 2019. Patent evidence, however, reveals a much broader intended category range: probiotic powders, hypoglycemic products, microbial preparations, microcapsules, health supplement compositions, acidic beverages, probiotic-enriched fresh produce, sports nutrition compositions, hair loss treatments, and pharmaceutical compositions for obesity or diabetes. The commercial evidence is therefore narrow, while patent activity indicates the ingredient is being developed across food, beverage, pharmaceutical, cosmetic, and agricultural domains.

Which product categories contain Bacillus coagulans?

Tracked product categories ranked by distinct products containing this ingredient.

Face Cream/Moisturizer1Face Wash1

Which formulation and co-ingredient patterns recur around bacillus coagulans?

Recurring formulation patterns center on spore stability and delivery systems. Patents describe microencapsulation with inulin and xanthan gum, freeze-drying protectants containing skim milk powder, fructooligosaccharides, and monosodium glutamate, and spore-based formulations designed to survive brewing, acidic room-temperature storage, and colonization of fresh produce tissue. Co-ingredient patterns include prebiotic fibers such as fructooligosaccharides, galactooligosaccharides, inulin, and polydextrose, plus pairing with other probiotic strains like Lactobacillus and Bifidobacterium species. These patterns indicate a focus on viability preservation and synbiotic combinations rather than simple standalone supplementation.

Which product spaces around bacillus coagulans appear crowded or differentiated?

Crowded patent spaces include metabolic health applications—blood glucose reduction, hypoglycemic effects, and α-glucosidase inhibition—with multiple patents covering similar strain-based approaches. Intestinal health and flora regulation also appear well represented. Differentiated spaces include polyamine-producing strains for hair growth and skin improvement, inactivated or dead bacillus coagulans for physical performance, spore-colonized fresh produce, and room-temperature acidic beverages with maintained spore viability. These less-crowded areas offer clearer differentiation opportunities, particularly where the mechanism extends beyond conventional probiotic activity.